The ability of different biological therapies to reduce the use of systemic steroids and the rate of asthma exacerbations in severe asthma: experience from a single center

Objective Biological therapies are used to treat patients with severe asthma (SA) with type 2 inflammation. These biologics have been shown to reduce oral corticosteroids and asthma exacerbations and improve patients’ quality of life. This study will examine the extent to which biological therapies...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Safwat Eldaabossi, Amgad Awad
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wolters Kluwer Medknow Publications 2021-01-01
Schriftenreihe:	Egyptian Journal of Chest Disease and Tuberculosis
Schlagworte:	asthma treatments biologics eosinophil monoclonal antibodies severe asthma
Online-Zugang:	http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2021;volume=70;issue=4;spage=447;epage=454;aulast=Eldaabossi
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!